These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15234849)

  • 1. HIV treatment in South African children.
    Neal LJ; Yoganathan K; Roux P
    Lancet; 2004 Jul 3-9; 364(9428):26. PubMed ID: 15234849
    [No Abstract]   [Full Text] [Related]  

  • 2. The dilemma of antiretroviral treatment.
    Ncayiyana DJ
    S Afr Med J; 2001 Jul; 91(7):529. PubMed ID: 11544955
    [No Abstract]   [Full Text] [Related]  

  • 3. Strengthening the health system and ensuring equity in the widescale implementation of an antiretroviral therapy programme in South Africa.
    Schneider H; Coetzee D
    S Afr Med J; 2003 Oct; 93(10):772-3. PubMed ID: 14652966
    [No Abstract]   [Full Text] [Related]  

  • 4. Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles.
    Ojikutu B; Jack C; Ramjee G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S523-7. PubMed ID: 18181705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa.
    Boulle A; Van Cutsem G; Hilderbrand K; Cragg C; Abrahams M; Mathee S; Ford N; Knight L; Osler M; Myers J; Goemaere E; Coetzee D; Maartens G
    AIDS; 2010 Feb; 24(4):563-72. PubMed ID: 20057311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SAMA takes the lead in HAART provision.
    Bateman C
    S Afr Med J; 2002 Oct; 92(10):750-1. PubMed ID: 12432791
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of abacavir in 30 HIV-infected children from Durban, South Africa: report from a pilot study.
    Bobat R; Kindra G; Kiepiela P; Reddy S; Jeena PM; Adhikari M; Coovadia HM
    Pediatr Infect Dis J; 2010 Sep; 29(9):890. PubMed ID: 20720476
    [No Abstract]   [Full Text] [Related]  

  • 8. Access to HIV drugs: are we changing the two world paradigm?
    Lazzarini Z
    Conn J Int Law; 2002; 17(2):281-96. PubMed ID: 12688297
    [No Abstract]   [Full Text] [Related]  

  • 9. Prisoners die as bureaucrats bicker.
    Bateman C
    S Afr Med J; 2006 Jun; 96(6):482-8. PubMed ID: 16841126
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell phones: tightening the communication gap in resource-limited antiretroviral programmes?
    Lester RT; Gelmon L; Plummer FA
    AIDS; 2006 Nov; 20(17):2242-4. PubMed ID: 17086071
    [No Abstract]   [Full Text] [Related]  

  • 11. Universal access to antiretroviral therapy: when, not if.
    Carpenter CC
    Clin Infect Dis; 2006 Jan; 42(2):260-1. PubMed ID: 16355338
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiretroviral therapy in children--increased benefit from increased complexity.
    Cotton MF
    S Afr Med J; 2000 Oct; 90(10):985-8. PubMed ID: 11081099
    [No Abstract]   [Full Text] [Related]  

  • 13. South Africa will not pay for antiretroviral therapy.
    Sidley P
    BMJ; 2001 Jun; 322(7300):1441. PubMed ID: 11408289
    [No Abstract]   [Full Text] [Related]  

  • 14. Pediatric highly active antiretroviral therapy in Africa: potential benefits of a family-centered model.
    Reddi A; Leeper SC; Sunpath H
    J Infect Dis; 2008 Sep; 198(6):938-9; author reply 939-40. PubMed ID: 18721063
    [No Abstract]   [Full Text] [Related]  

  • 15. Reasons for delay in initiation of antiretroviral therapy in a population of HIV-infected South African children.
    Feucht UD; Kinzer M; Kruger M
    J Trop Pediatr; 2007 Dec; 53(6):398-402. PubMed ID: 17965099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Access of abandoned children and orphans with HIV/AIDS to antiretroviral therapy--a legal impasse.
    Gerntholtz L; Richter M
    S Afr Med J; 2004 Nov; 94(11):910-2. PubMed ID: 15587454
    [No Abstract]   [Full Text] [Related]  

  • 17. The imperative to treat: the South African state's constitutional obligations to provide antiretroviral medicines.
    Forman L
    Health Law Rev; 2003; 12(1):9-15. PubMed ID: 15742491
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges to pediatric HIV care and treatment in South Africa.
    Meyers T; Moultrie H; Naidoo K; Cotton M; Eley B; Sherman G
    J Infect Dis; 2007 Dec; 196 Suppl 3():S474-81. PubMed ID: 18181697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary outcomes of a paediatric highly active antiretroviral therapy cohort from KwaZulu-Natal, South Africa.
    Reddi A; Leeper SC; Grobler AC; Geddes R; France KH; Dorse GL; Vlok WJ; Mntambo M; Thomas M; Nixon K; Holst HL; Karim QA; Rollins NC; Coovadia HM; Giddy J
    BMC Pediatr; 2007 Mar; 7():13. PubMed ID: 17367540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological suppression achieved with suboptimal adherence levels among South African children receiving boosted protease inhibitor-based antiretroviral therapy.
    Müller AD; Myer L; Jaspan H
    Clin Infect Dis; 2009 Jan; 48(1):e3-5. PubMed ID: 19025495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.